Intravenous Busulfan Pharmacokinetics in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Dosing Weight

被引:0
|
作者
Bradley, Amber M. [1 ,2 ]
Evans, Sarah [2 ]
DeRemer, David [1 ,2 ]
Awan, Farrukh Tauseef [3 ]
机构
[1] Georgia Hlth Sci Med Ctr, Augusta, GA USA
[2] Univ Georgia, Coll Pharm, Augusta, GA USA
[3] Georgia Hlth Sci Univ, Augusta, GA USA
关键词
D O I
10.1016/j.bbmt.2012.11.605
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
540
引用
收藏
页码:S373 / S374
页数:2
相关论文
共 50 条
  • [31] Influence of Fludarabine on the Pharmacokinetics of Oral Busulfan During Pretransplant Conditioning for Hematopoietic Stem Cell Transplantation
    de Castro, Francine Attie
    Lanchote, Vera Lucia
    Voltarelli, Julio Cesar
    Rensi Colturato, Virgilio Antonio
    Simoes, Belinda Pinto
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (11): : 1205 - 1211
  • [32] Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation
    US Schuler
    M Ehrsam
    A Schneider
    H Schmidt
    J Deeg
    G Ehninger
    Bone Marrow Transplantation, 1998, 22 : 241 - 244
  • [33] Individualized once-daily dosing of intravenous busulfan: a pharmacokinetic study in patients undergoing conditioning for allogeneic stem cell transplantation.
    Kangarloo, SB
    Naveed, F
    Andersson, BS
    Quinlan, D
    Russell, JA
    BLOOD, 2004, 104 (11) : 31A - 32A
  • [34] Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation
    Schuler, US
    Ehrsam, M
    Schneider, A
    Schmidt, H
    Deeg, J
    Ehninger, G
    BONE MARROW TRANSPLANTATION, 1998, 22 (03) : 241 - 244
  • [35] A new IV Busulfan fixed dosing as part of BuMel or BuCy conditioning regimens:: A pharmacokinetic/pharmacodynamic study in pediatric patients undergoing autologous or allogeneic hematopoietic stem cell transplantation
    Vassal, G
    Esperou, H
    Valteau-Couanet, D
    Gentet, JC
    Doz, F
    Méchinaud, F
    Galambrun, C
    Fischer, A
    Zouabi, H
    Nguyen, L
    Michel, G
    BLOOD, 2005, 106 (11) : 384B - 384B
  • [36] Comparison Between Busulfan with Cyclophosphamide and Busulfan with Fludarabine As Myeloablative Conditioning of Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies
    Mori, Takehiko
    Ohashi, Kazuteru
    Kanamori, Heiwa
    Sakura, Toru
    Yano, Shingo
    Kanda, Yoshinobu
    Kako, Shinichi
    Tachibana, Takayoshi
    Yokota, Akira
    Onizuka, Makoto
    Nakaseko, Chiaki
    Okamoto, Shinichiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S204 - S204
  • [37] The Optimal Busulfan Dose of Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation in Younger Patients with Acute Myeloid Leukemia
    Choi, Yunsuk
    Choi, Eun-Ji
    Park, Han-Seung
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Lee, Young-Shin
    Kang, Young-A
    Jeon, Mijin
    Woo, Ji Min
    Kang, Hyeran
    Lee, Je-Hwan
    BLOOD, 2023, 142
  • [38] Population pharmacokinetics analysis of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation
    Wu, Xuemei
    Xie, Helin
    Lin, Weiwei
    Yang, Ting
    Li, Nainong
    Lin, Shanshan
    Yuan, Xiaohong
    Ren, Jinhua
    Li, Xiaofan
    Huang, Xian
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 (05): : 529 - 538
  • [39] Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantation
    Cremers, S
    Schoemaker, R
    Bredius, R
    den Hartigh, J
    Ball, L
    Twiss, I
    Vermeij, P
    Vossen, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) : 386 - 389
  • [40] Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation:: Study of pharmacokinetics and early clinical outcomes
    Russell, JA
    Tran, HT
    Quinlan, D
    Chaudhry, A
    Duggan, P
    Brown, C
    Stewart, D
    Ruether, JD
    Morris, D
    Glück, S
    Gyonyor, E
    Andersson, BS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (09) : 468 - 476